Literature DB >> 26372424

Negative regulation of natural killer cell in tumor tissue and peripheral blood of oral squamous cell carcinoma.

Anupam Dutta1, Arunabha Banerjee1, Nabajyoti Saikia2, Jyotirmoy Phookan3, Munindra Narayan Baruah4, Shashi Baruah5.   

Abstract

Natural killer (NK) cells are the key lymphocytes in solid tumors. Its activity is regulated by both germline encoded receptors and cytokine microenvironment. We conducted a case-control study to investigate the activation status of NK cell in oral squamous cell carcinoma (OSCC). NK cell activation was assessed in context of NK cell cytotoxicity and transcript expression of NK cell receptors (NKp46 and KIRs) and NK cell associated cytokines (IL-1β, IL-2, IL-10, IL-12β, IL-15, IL-18, IL-21, IFN-γ, TNF-α and TGF-β). The results revealed possible mechanisms involved in reduced NK cell activation in peripheral circulation: quantitative deficiency of NK cell number and lowered cytotoxicity together with qualitative NK impairments caused by--(1) decreased expression of NK activating receptor NKp46, (2) increased expression of NK suppressive cytokines--IL-10 and TGF-β and (3) induction of FOXP3(+)CTLA4(+) suppressor cells. On the other hand, in the tumor tissue, escape of NK immune surveillance appeared to be modulated by upregulation of TGF-β and IL-10 together with downregulation of NK cell activating cytokines (IL-2, IL-12β, IL-15, IL-18, IL-21 and IFN-γ) and NK receptors (NKp46 and KIRs). In addition, our study supported the earlier contention that TNF-α and IL-1β expression levels may be used as markers of malignant transformation in oral leukoplakia. In conclusion, the study provided an insight into the negative regulation of NK cell in tumor tissue and peripheral blood of OSCC patients, which can be exploited to boost the current NK cell and cytokine based immunotherapy for the treatment of oral cancer.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokine; Cytotoxic T-Lymphocyte-Associated Antigen 4; Forkhead Box P3; Killer cell immunoglobulin-like receptor; Natural killer cell; Oral squamous cell carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26372424     DOI: 10.1016/j.cyto.2015.09.006

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  12 in total

1.  Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia.

Authors:  James S Brown
Journal:  Schizophr Bull       Date:  2016-05-11       Impact factor: 9.306

Review 2.  The role of transforming growth factor-beta in immune suppression and chronic inflammation of squamous cell carcinomas.

Authors:  Alexander A Strait; Xiao-Jing Wang
Journal:  Mol Carcinog       Date:  2020-04-17       Impact factor: 4.784

3.  TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.

Authors:  Hung C Tran; Zesheng Wan; Michael A Sheard; Jianping Sun; Jeremy R Jackson; Jemily Malvar; Yibing Xu; Larry Wang; Richard Sposto; Eugene S Kim; Shahab Asgharzadeh; Robert C Seeger
Journal:  Clin Cancer Res       Date:  2016-10-10       Impact factor: 12.531

4.  NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer.

Authors:  Paweł Piątkiewicz; Małgorzata Bernat-Karpińska; Tomasz Miłek; Michał Rabijewski; Elżbieta Rosiak
Journal:  Diabetol Metab Syndr       Date:  2016-06-13       Impact factor: 3.320

5.  Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway.

Authors:  Yang Xia; Qiongfang Zhang; Quan Zhen; Yan Zhao; Nanjing Liu; Ting Li; Yanni Hao; Yao Zhang; Chunli Luo; Xiaohou Wu
Journal:  Oncotarget       Date:  2017-06-06

Review 6.  The Common Costimulatory and Coinhibitory Signaling Molecules in Head and Neck Squamous Cell Carcinoma.

Authors:  Peng Liao; Haofan Wang; Ya-Ling Tang; Ya-Jie Tang; Xin-Hua Liang
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

7.  Prognostic Potential of Tumor-Infiltrating Immune Cells in Resectable Oral Squamous Cell Carcinoma.

Authors:  Ana Caruntu; Liliana Moraru; Mihai Lupu; Florina Vasilescu; Marius Dumitrescu; Mirela Cioplea; Cristiana Popp; Alexandra Dragusin; Constantin Caruntu; Sabina Zurac
Journal:  Cancers (Basel)       Date:  2021-05-08       Impact factor: 6.639

8.  LY2157299 Monohydrate, a TGF-βR1 Inhibitor, Suppresses Tumor Growth and Ascites Development in Ovarian Cancer.

Authors:  Qing Zhang; Xiaonan Hou; Bradley J Evans; Jamison L VanBlaricom; Saravut J Weroha; William A Cliby
Journal:  Cancers (Basel)       Date:  2018-08-07       Impact factor: 6.639

Review 9.  Immunomodulatory aspects in the progression and treatment of oral malignancy.

Authors:  Nobuo Kondoh; Masako Mizuno-Kamiya; Naoki Umemura; Eiji Takayama; Harumi Kawaki; Kenji Mitsudo; Yasunori Muramatsu; Shinichiro Sumitomo
Journal:  Jpn Dent Sci Rev       Date:  2019-10-07

Review 10.  The Crossroads of Periodontitis and Oral Squamous Cell Carcinoma: Immune Implications and Tumor Promoting Capacities.

Authors:  Omnia Elebyary; Abdelahhad Barbour; Noah Fine; Howard C Tenenbaum; Michael Glogauer
Journal:  Front Oral Health       Date:  2021-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.